U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Purchased by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board boosted its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 3,666.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,300 shares of the company's stock after purchasing an additional 11,000 shares during the period. Canada Pension Plan Investment Board owned approximately 0.07% of U.S. Physical Therapy worth $1,002,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of USPH. Marshall Wace LLP lifted its holdings in U.S. Physical Therapy by 3.7% during the 4th quarter. Marshall Wace LLP now owns 44,534 shares of the company's stock valued at $3,951,000 after buying an additional 1,591 shares in the last quarter. Barclays PLC raised its stake in shares of U.S. Physical Therapy by 3.1% during the fourth quarter. Barclays PLC now owns 27,532 shares of the company's stock valued at $2,442,000 after acquiring an additional 823 shares in the last quarter. Rockefeller Capital Management L.P. boosted its holdings in shares of U.S. Physical Therapy by 17.4% in the fourth quarter. Rockefeller Capital Management L.P. now owns 188,279 shares of the company's stock valued at $16,702,000 after purchasing an additional 27,838 shares during the period. Sterling Capital Management LLC grew its stake in U.S. Physical Therapy by 18.6% in the fourth quarter. Sterling Capital Management LLC now owns 15,430 shares of the company's stock worth $1,369,000 after purchasing an additional 2,425 shares in the last quarter. Finally, Kennedy Capital Management LLC increased its holdings in U.S. Physical Therapy by 7.4% during the 4th quarter. Kennedy Capital Management LLC now owns 79,551 shares of the company's stock worth $7,057,000 after purchasing an additional 5,496 shares during the period.

U.S. Physical Therapy Stock Performance

Shares of NYSE USPH traded down $0.32 during midday trading on Wednesday, reaching $71.28. The company had a trading volume of 114,401 shares, compared to its average volume of 107,846. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $108.14. The business's 50-day simple moving average is $73.75 and its 200 day simple moving average is $84.22. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The stock has a market cap of $1.08 billion, a P/E ratio of 75.83, a P/E/G ratio of 3.54 and a beta of 1.38.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). The firm had revenue of $180.45 million for the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. On average, analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 14th were issued a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.53%. The ex-dividend date of this dividend was Friday, March 14th. This is an increase from U.S. Physical Therapy's previous quarterly dividend of $0.44. U.S. Physical Therapy's dividend payout ratio is 97.83%.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on USPH shares. StockNews.com lowered U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research note on Thursday, April 17th. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Barrington Research decreased their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. JPMorgan Chase & Co. cut their target price on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 19th. Finally, JMP Securities reissued a "market outperform" rating and set a $113.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $109.00.

Insider Buying and Selling at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the business's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the transaction, the chief operating officer now owns 7,168 shares of the company's stock, valued at $588,564.48. The trade was a 19.44 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 2.00% of the company's stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.